Clearing the path to clinical trials
カプセルの入手可能性は、臨床開発の初期段階の隠れたボトルネックとなることが多くあります。The new Capsugel® CapsuleCaddy® program, available for customers located in EMEA, removes that barrier, giving you immediate access to GMP capsules in clinically relevant quantities, so you can move from formulation to first-in-human faster.
Download the brochure to learn more about the CapsuleCaddy® options available from stock, supporting diverse formulation strategies and clinical requirements.
* Please note that this program is for EMEA customers only, contact your customer representative to learn more about the CapsuleCaddy® program available in other regions
Latest CHI content